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Similar results were obtained after adjustment for MI and hypemholestere~emia. 
Conclusion: This case-contrel study provides evidence that current HRT use neither 
increases nor decreases the risk of incident MI in postmenopausel women with diabetes. 
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825FO-5 Prothrombotic Mutations Are Associated With 
Increased Cardiovascular Events in Postmenopausal 
Women Receiving Hormone Replacement Therapy 
Francesco Dragoni, Otavio Gebara, Massimo Fini, Mauricio Wajngarten, Jost~ Mendes 
Alddghi, Giuseppe Mercuro, Jos~ Antonio F. Ramires, GiuseoDe M. Rosano. San 
Raffaele Hospital, Roma, Italy, INCOR, Sao Paulo, Brazil. 
Recent studies have suggested that hormone replacement therapy (HRT) in postmeno- 
pausal women (PMW) may be associated with an initial increased cardiovascular isk. 
Recent reports suggest that the prothrombin variant 20210G to A is associated with an 
increased risk of events in hypertensive PMW with a previous myocardial infarction. To 
this end 50 PMW with documented vascular event underwent prospective valuation of 
antithrombin III, protein C, free and total protein S, activated protein C resistance, fibrino- 
gen, factor VII:C and homocysteine levels. In all the presence of antiphospholipid anti- 
bodies was investigated by kaolin clotting time (KCT), diluted Russers viper venom time 
(DRVVT) end by measurement of anticardiolipin antibodies IgG and IgM (ACA-G and 
ACA-M). Prevalence of factor V Leiden, prothrombin variant G20210A and homozygosity 
for thermolabile variant C677T of the metilenetetrahydrofolate reductase (MTHFR) were 
evaluated and compared with those of 50 normal matched controls. 
Antithrombin l and protein C were normal in all cases. One patient (2%) showed free 
protein S deficiency and 3 patients (6%) had activated protein C resistance. Homocys- 
teine levels above 15 tJmol/L were found in 3 patients (6%). Antiphospholipids antibodies 
were found in 35 patients (70%). Among women receiving HRT 87% had combined 
inhedted and acquired prothrombotic factors (OR = 37.3, 95% CI = 8.5-564.3) while no 
combined prothrombotic factors were found in control PMW receiving HRT. 
In conclusion vascular events in women receiving RRT are associated with a high preva- 
lence of combined inherited and acquired prothrombotic factors. Therefore screening for 
prothrombotic factors may be of help in identify those women at increased risk for cardio- 
vascular events with HRT. 
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Cdstiana Vitale, Otavio Gebara, Massimo Fini, Mauricio Wajngarten, Jos~ Mendes 
Alddghi, Antonello SUvestd, Paola Rossini, Sandra Zoncu, Cdstiano Sarais, Jos~ Antonio 
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Menopause is associated with an increased cardiovascular isk and with a decrease in 
endothelial function Hormone replacement herapy (HRT) improves endothelial function 
in post-menopausal women (PMW). New alternative treatments for menopausal women 
have been suggested among these Tibolone iT) and di-hydroepiandresterone sulphate 
(DHEAS) have been suggested to have cardioprotsctive ffects, Although in vitro animal 
studies have suggested that T and DHEAS improve endothelial function, their effect in 
humans has never been tested, Aim of the present study was to compare the effects of 
HRT, DHEAS and T on endothelium-dependent flow mediated vasodilation (FMD), 
plasma nitrite, nitrate and endothelin-1 in 16 PMW with increased cardiovascular isk in a 
double-blinded double-crossover study. Women were randomized and treated for 4 
weeks with either HRT, T or DHEAS. Brachial artery diameter, FMD, endothelin-1 and 
plasma nitrite and nitrate levels were measured at baseline and after each treatment 
- phase.Brachial artery diameters remained unchanged after each treatment phase. HRT 
significantly improved FMD compared to both baseline and T and DHEAS while no effect 
of T or DHEAS on FMD was noted. 
In conclusion HRT but not either T or DHEAS improves endothelial function and reduces 
plasma levels of endothelin-t in PMW at risk of CAD. 
Effect of HRT, Tibolone or DHEAS on Endothelial Function 
Baseline HRT T DHEAS 
Brachial artery (mm) 4,06±0.3 4.0.7±0.3 4.07±0.2 4.06±0.3 
FMD (%) 7.3±0.8 11,94±0.8"* 6.9±0.5 6.4±0.9 
Nitrite+nitrate (Nox) 40 .6±11.7  48.4±7.8 39.9±8.2 34.7±11.8 
Endothelin-1 (pg/ml) 3.1±0,8 2.7±0.7* 3.1¢1.7 3.4±0.7 
*=p<0.05; **=p<0.01 
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1128-85 Effect of the Anglotenslnogen M235T Polymorphism on 
Human Coronary Vascular Endothelial FuncUon 
Julian Halcox. Suresh Narayanan, Abhiram Prasad, Colleen Satorius, William H. 
Schenke, Neal Epstein, Arshed A. Quyyumi, NHLB/, Bethesda, Maryland. 
Introduction: A missense substitution in exon 2 of the angiotensinogen gene (T704-C) 
encoding threonine instead of methionine at position 235 (M235T) may influence the risk of 
vascular disease. We hypothesized that this polymorphism is associated with coronary 
vascular endothelial dysfunction. 
Methods; Angiotensinogen M235T genotyping was performed in 118 Caucasian patients 
with mild coronary atherosclerosis (<50% stenosis) or angiographically smooth coronary 
artedes undergoing cardiac catheterization. Changes in coronary vascular resistance 
(~CVR) and epicardial artery diameter (aD) were measured as indices of microvascular 
and epicardial coronary vasodilator capacity during administration of intra-coronary acatyl- 
choline (ACH, 1511g/min), and sodium nitroprosside (SNP, 20pg/min), to test endothelium- 
dependent and -independent coronary vascular function, respectively. 
Results: 235T allele frequency was 0.40. Coronary microvascular dilation with ACH was 
reduced in TT compared to MT+'I-I" patients (SCVR: -36±9% vs -49±6%, p--O.04), whereas 
responses to SNP were similar in both groups (~CVR: .48±7% vs -54±2%, p=0.35]). In the 
epicardial coronary circulation, a net vasoconstrictor response with ACH was observed in 
l-r individuals, compared with a net vascdiletor esponse in MM+MT subjects (-5.2+~.3% 
vs +2.2±1.0%, p=0.003). Epicardial responses to SNP were similar in TT and MM+TT gen- 
otype groups (+23±5% vs +21±.2%, p=0.73). This impaired microvascular and epicardial 
coronary endothelial function observed in TT patients was independent of conventional dsk 
factors (age, gender, smoking, hyperlipidemia, diabetes, hypertension) for endothelial dys- 
function by multivariate analysis (~CVR: p=0.04 and 5D: p=O.03). 
Conclusions: individuals homozygous for the engiotensinogen 235T allele have impaired 
endothelium-dependent coronary artery vascdilation compared with MM+MT subjects. 
This finding provides mechanistic insight into the increased association between the 235T 
allele and hypertension, atherosclerosis, and myocardial infarction observed in several epi- 
demiologic studies. 
1128-86 Endothelial Dysfunction Following Radial Artery 
Cannulization 
Michael G. Del Core, Christopher Price, Lance LaMadrid, Kay Ryshon, Syed M. 
Mohiuddin, Creighton University, Omaha, Nebraska. 
Background: There is an increasing tendency to use arterial conduits, including the radial 
artery iRA), for coronary artery bypass surgery. At the same time, invasive cardiologists 
are increasingly using the RA as a conduit for cardiac catheterization. The purpose of 
this study was to assess endothelial function following RA cannulization. Methods: 20 
patients scheduled to undergo diagnostic catheterization via the radial approach under- 
went non-invasive evaluation of endothelial function. RA diameter was measured at 
baseline, then at 30 and 90 seconds following reactive hyperemia (endothelial depen- 
dent), and following administration of Nitroglycerin (endothelial independent). These 
measurements were obtained prior to catheterization, within 24 hours, at one week, and 
at one month following catheterization, Results: Reduced endothelial function in the RA 
was evident 24 hours after catheterization regardless of the dilation technique. Endothe- 
lial function measured at 1 week and 1 month in the radial artery was significantly 
improved over 24 hour values for nitro at 30 seconds (p=0.023 and p=0.016, respec- 
tively), and cuff at g0 seconds (p=0.045 and p=0.026, respectively). Nonsignificant 
improvements in endothelial function were evident at the remaining interventions 
between 1 week and 1 month. 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Pie Ca~h 24 Ham"s 1 Week 1 
Conclusion: RA catheterization results in endothelial dysfunction following catheteriza- 
tion and may have implications for its use as an arterial conduit in coronary artery bypass 
surgery, 
1128-87 Effect of Xanthine Oxidase Inhibition on Endothelial 
Function in Smokers 
Sasidhar Guthikonda. Christine Sinkey, Theresa Barenz, William G. Haynes, Univeraity 
of Iowa, Iowa Ci~ Iowa. 
Background: Cigarette smoking causes endothelial dysfunction, possibly due to oxidant 
stress. One proposed mechanism has been generation of oxidant species by the enzyme 
xanthine oxidase (XO). We tested the hypothesis that XO impairs endothelial function in 
